ELIZABETH SOSEBEE: Open Payments
NPI 1902531106 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 30 payments from 13 companies in 2025. Trend: 2023 $632 · 2024 $726 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $208 |
| Medtronic, Inc. | 2 | $143 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $110 |
| Novo Nordisk Inc | 1 | $102 |
| Merck Sharp & Dohme LLC | 4 | $69 |
| United Therapeutics Corporation | 2 | $56 |
| PFIZER INC. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Recor Medical Inc | 1 | $19 |
Products named: SYMPLICITY G3, LifeVest, Ozempic, REPATHA, Tyvaso, VERQUVO, VYNDAQEL, JARDIANCE.
Industry payments across AL — which companies pay providers there.
